Literature DB >> 32877584

Spectrum of Fibrotic Lung Diseases.

Marlies Wijsenbeek1, Vincent Cottin1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32877584     DOI： 10.1056/NEJMra2005230

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  Molecular approach to the classification of chronic fibrosing lung disease-there and back again.

Authors:  Stijn E Verleden; Peter Braubach; Mark Kuehnel; Nicolas Dickgreber; Emily Brouwer; Pauline Tittmann; Florian Laenger; Danny Jonigk
Journal:  Virchows Arch       Date:  2020-11-09       Impact factor: 4.064

2.  Home monitoring for patients with ILD and the COVID-19 pandemic.

Authors:  G Nakshbandi; C C Moor; M S Wijsenbeek
Journal:  Lancet Respir Med       Date:  2020-10-16       Impact factor: 30.700

Review 3.  Update in Interstitial Lung Disease 2020.

Authors:  Anna J Podolanczuk; Alyson W Wong; Shigeki Saito; Joseph A Lasky; Christopher J Ryerson; Oliver Eickelberg
Journal:  Am J Respir Crit Care Med       Date:  2021-06-01       Impact factor: 21.405

4.  MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice.

Authors:  Jingyi Pan; Xinyu Li; Shengwei Jin; Hui Li; Xinyang Wang; Lili Yang; Houlin Chen; Nana Su; Chenghua Wu; Yu Hao
Journal:  J Inflamm Res       Date:  2021-05-11

5.  Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).

Authors:  Mouhamad Nasser; Sophie Larrieu; Loic Boussel; Salim Si-Mohamed; Fabienne Bazin; Sébastien Marque; Jacques Massol; Françoise Thivolet-Bejui; Lara Chalabreysse; Delphine Maucort-Boulch; Eric Hachulla; Stéphane Jouneau; Katell Le Lay; Vincent Cottin
Journal:  Respir Res       Date:  2021-05-24

Review 6.  Familial Pulmonary Fibrosis: Genetic Features and Clinical Implications.

Authors:  David Zhang; Chad A Newton
Journal:  Chest       Date:  2021-06-26       Impact factor: 9.410

Review 7.  Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis.

Authors:  Yoshitoshi Kasuya; Jun-Dal Kim; Masahiko Hatano; Koichiro Tatsumi; Shuichi Matsuda
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

8.  Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.

Authors:  Tao Chen; Amy Po Yu Tsai; Seo Am Hur; Alyson W Wong; Mohsen Sadatsafavi; Jolene H Fisher; Kerri A Johannson; Deborah Assayag; Julie Morisset; Shane Shapera; Nasreen Khalil; Charlene D Fell; Helene Manganas; Gerard Cox; Teresa To; Andrea S Gershon; Nathan Hambly; Andrew J Halayko; Pearce G Wilcox; Martin Kolb; Christopher J Ryerson
Journal:  Respir Res       Date:  2021-07-08

9.  Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Stefan F H Neys; Peter Heukels; Jennifer A C van Hulst; Jasper Rip; Marlies S Wijsenbeek; Rudi W Hendriks; Odilia B J Corneth
Journal:  Cells       Date:  2021-05-26       Impact factor: 6.600

Review 10.  Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases.

Authors:  Yuling Huang; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2021-08-04       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.